Gyon Technologies Capital Management, LP Iveric Bio, Inc. Transaction History

Gyon Technologies Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$17.24 - $23.95 $58,581 - $81,382	-3,398 Reduced 25.63%	9,861 $211,000
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $282,535 - $558,759	-30,057 Reduced 69.39%	13,259 $238,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $395,041 - $818,672	43,316 New	43,316 $417,000
Q1 2022 May 12, 2022	SELL	$12.15 - $16.83 $221,336 - $306,592	-18,217 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$13.83 - $18.78 $251,941 - $342,115	18,217 New	18,217 $305,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.